Privacy Statement   Terms & Conditions   Sitemap  
       
 
 
 

Baxter Receives EMEA Positive Opinion for CELVAPAN, the First Cell Culture-based Pandemic Flu Vaccine
» read more

The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxter's Cell-Based Pandemic, Avian Flu Vaccine
» read more

U.S. Department of Health and Human Services Completes Funding of 2006 Contract Award to CSC?s DVC and Baxter
» read more

 
 
  » find
 
 
Baxter Vaccines Industriestrasse 67, A-1221 Wien, Tel: +43-1-20100,